Full-Time

Sr. Medical Science Writer

Posted on 3/7/2025

Medtronic

Medtronic

10,001+ employees

Develops and manufactures medical devices and therapies

Compensation Overview

$103.2k - $154.8k/yr

+ Short-term Incentive Plan

Senior

Brooklyn Park, MN, USA

This position can be remote from anywhere within the United States or work a hybrid schedule at our Fridley, Minnesota site.

Category
Technical Writing
Content & Writing
Medical, Clinical & Veterinary
Copywriting
Requirements
  • Requires a Baccalaureate degree
  • Minimum of 4 years of relevant experience, or advanced degree with a minimum of 2 years relevant experience.
Responsibilities
  • Develop clinical strategy and author clinical documents including but not limited to clinical study synopses, clinical study reports, clinical evaluation plans/reports, annual progress reports, clinical risk benefit analyses, and clinical marketing materials.
  • Collaborate with cross-functional teams, such as marketing, sales, clinical, R&D, HE&R, Quality, Compliance and Regulatory, and may represent clinical on core teams for new product development and/or product expansions.
  • Develop and maintain strong scientific knowledge of the therapeutic area, disease state, and current competitive landscape, with the ability to effectively write key clinical deliverables/sections of regulatory submissions, including regulatory responses.
  • Develop a deep understanding of clinical data: how to interpret and effectively communicate/present the data.
  • Design literature searches using relevant key words.
  • Develop and maintain an accessible repository for relevant Medtronic and competitive literature.
  • Follow Medtronic Code of Conduct, SOPs, ICMJE and other related guidelines.
  • 25% or less domestic travel.
Desired Qualifications
  • Master of Science, PhD or PharmD
  • Demonstrated scientific writing experience, expertise in literature identification and analysis, advanced presentation skills
  • Knowledge of clinical research methodology, tools, processes and regulations
  • Ability to critically analyze and interpret scientific data, understanding of statistical methods
  • Experience conducting focused literature searches on PubMed, Embase, MedLine, or other similar medical literature databases
  • Ability to build and foster relationships with KOLs and key business stakeholders.
  • Highly motivated and capable of comprehending large amounts of scientific content, which is then communicated in a clear, concise fashion
  • Neuromodulation medical device experience or other implantable medical device

Medtronic provides medical technology and solutions to improve patient care across various health conditions. The company develops and manufactures a wide range of medical devices, including pacemakers, insulin pumps, surgical tools, and neurostimulation devices. These products help diagnose, prevent, and treat chronic diseases. Medtronic's business model focuses on research and development, manufacturing, and sales, ensuring that healthcare providers have access to the latest medical technologies. Unlike many competitors, Medtronic also offers additional services such as training for healthcare professionals and patient management programs, which enhance the effectiveness of their products. The company's goal is to improve patient outcomes and reduce healthcare costs through comprehensive healthcare solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Fridley, Minnesota

Founded

1949

Simplify Jobs

Simplify's Take

What believers are saying

  • Medtronic's acquisition of Bellco expands its renal care solutions portfolio.
  • The Evolut TAVR system shows superior performance in recent clinical trials.
  • Medtronic's 10-year initiative aims to propel 1M students into health tech careers.

What critics are saying

  • Emerging competitors threaten Medtronic's market share in cardiovascular and diabetes sectors.
  • Technological advancements may outpace Medtronic's R&D capabilities, risking product obsolescence.
  • Supply chain vulnerabilities, like semiconductor shortages, could impact device production.

What makes Medtronic unique

  • Medtronic's global presence spans over 150 countries, enhancing its market reach.
  • The company invests heavily in R&D, driving innovation in medical technology.
  • Medtronic offers comprehensive healthcare solutions, including training and technical support.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Company News

Medtronic
Mar 14th, 2025
Medtronic Adds Life-Extending Dialysis Portfolio to Recently Formed Renal Care Solutions Business with Acquisition of Bellco

DUBLIN - February 1, 2016 - Furthering its commitment to improve outcomes, expand therapy access, and optimize costs and efficiencies in end stage renal disease (ESRD), Medtronic plc (NYSE: MDT)...

Business Wire
Mar 11th, 2025
nVent Announces New Executive Leadership Appointments

Gary joins nVent from Medtronic, where he serves as Senior Vice President, Corporate Finance after serving as Interim Chief Financial Officer from August 2024 to March 2025.

Charities.org
Mar 11th, 2025
Sustainability News provided by 3BL

Medtronic named one of the 2025 World's Most Ethical Companies for the third time by Ethisphere.

Medical Device Network
Mar 10th, 2025
Medtronic announces two-year trial outcomes of Evolut TAVR

Medtronic has announced the Small Annuli Randomized To Evolut or SAPIEN (SMART) head-to-head comparative trial's two-year outcomes of the Evolut transfemoral transcatheter aortic valve replacement (TAVR) for aortic stenosis (AS) and small aortic annulus.

DiCardiology
Mar 10th, 2025
Medtronic Presents New Data, Clinical Milestones at CRT 2025

Medtronic presents new data, clinical milestones at CRT 2025.

INACTIVE